glp 1 gip and glucagon LY3437943, a novel triple glucagon, GIP, GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Effects, working principles and target
Description
A study linking statins, the microbiome, and blood sugar control doesnt change clinical practice
President Trump hailed his deal with pharma companies on GLP-1 drug pricing
Can GLP-1 medications reduce cravings for more than food
Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar
GLP-1 gallbladder risk is gaining attention in 2026
